Lumos Pharma Inc LUMO
€4.34
Last Updated: Dec 13, 12:00 AM·XFRA
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Lumos Pharma Inc Stock Halal?
Shariah Compliance Analysis of LUMO Stock
Germany Health Care Nano Cap No. As of September 2026, Lumos Pharma Inc (LUMO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Lumos Pharma Inc does not pass Musaffa's business and financial screening criteria.
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. The company is headquartered in Austin, Texas and currently employs 30 full-time employees. The company went IPO on 2011-11-11. The firm is engaged in advancing its clinical program and focused on identifying, acquiring, developing, and commercializing products and new therapies for people with rare diseases. Its pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders that require injectable recombinant human growth hormone (rhGH). LUM-201 is a tablet formulation that is intended to be administered once daily. LUM-201 stimulates GH via the GH secretagogue receptor (GHSR1a), also known as the ghrelin receptor, and also suppresses the release of somatostatin, thus providing a differentiated mechanism of action to treat some rare endocrine disorders (involving a deficiency of GH) by increasing the amplitude of endogenous, pulsatile GH secretion. Lumos Pharma Sub, Inc. (Private Lumos) is its subsidiary.
LUMO Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Lumos Pharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lumos Pharma Inc (LUMO) Chart
Financial Metrics & Statements of Lumos Pharma Inc (LUMO)
FAQ's for Lumos Pharma Inc (LUMO)
- As of September 2026, Lumos Pharma Inc LUMO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lumos Pharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lumos Pharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lumos Pharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lumos Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lumos Pharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lumos Pharma Inc (LUMO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
